183 related articles for article (PubMed ID: 24517435)
21. An Unbiased Machine Learning Exploration Reveals Gene Sets Predictive of Allograft Tolerance After Kidney Transplantation.
Fu Q; Agarwal D; Deng K; Matheson R; Yang H; Wei L; Ran Q; Deng S; Markmann JF
Front Immunol; 2021; 12():695806. PubMed ID: 34305931
[TBL] [Abstract][Full Text] [Related]
22. Lymphocyte markers and prediction of long-term renal allograft acceptance.
Babel N; Reinke P; Volk HD
Curr Opin Nephrol Hypertens; 2009 Nov; 18(6):489-94. PubMed ID: 19724222
[TBL] [Abstract][Full Text] [Related]
23. Sirolimus in renal transplantation: analysis of safety and efficacy in a nonprotocol conversion group.
Gois PH; Rivelli GG; Pereira LM; Mazzali M
Transplant Proc; 2012 Oct; 44(8):2348-51. PubMed ID: 23026590
[TBL] [Abstract][Full Text] [Related]
24. Unique aspects of rejection and tolerance in liver transplantation.
Knechtle SJ; Kwun J
Semin Liver Dis; 2009 Feb; 29(1):91-101. PubMed ID: 19235662
[TBL] [Abstract][Full Text] [Related]
25. Some observations on prope tolerance.
Calne R; Watson CJ
Curr Opin Organ Transplant; 2011 Aug; 16(4):353-8. PubMed ID: 21666472
[TBL] [Abstract][Full Text] [Related]
26. Steroid-free maintenance immunosuppression and ABO-incompatible transplantation.
Gloor J; Matas AJ
Transplantation; 2010 Mar; 89(6):648-9. PubMed ID: 20010327
[No Abstract] [Full Text] [Related]
27. Review: Pharmacodynamic monitoring of immunosuppression in kidney transplantation.
Barraclough KA; Staatz CE; Isbel NM; McTaggart SJ
Nephrology (Carlton); 2010 Aug; 15(5):522-32. PubMed ID: 20649871
[TBL] [Abstract][Full Text] [Related]
28. A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients.
Hatakeyama S; Fujita T; Yoneyama T; Yoneyama T; Koie T; Hashimoto Y; Saitoh H; Funyu T; Narumi S; Ohyama C
Transplant Proc; 2012 Jan; 44(1):121-3. PubMed ID: 22310594
[TBL] [Abstract][Full Text] [Related]
29. New evidence for a role of allograft accommodation in long-term tolerance.
Heslan JM; Renaudin K; Thebault P; Josien R; Cuturi MC; Chiffoleau E
Transplantation; 2006 Nov; 82(9):1185-93. PubMed ID: 17102770
[TBL] [Abstract][Full Text] [Related]
30. Evaluating safety and efficacy of rabbit antithymocyte globulin induction in elderly kidney transplant recipients.
Khanmoradi K; Knorr JP; Feyssa EL; Parsikia A; Jawa P; Dinh DB; Campos S; Zaki RF; Ortiz JA
Exp Clin Transplant; 2013 Jun; 11(3):222-8. PubMed ID: 23432665
[TBL] [Abstract][Full Text] [Related]
31. Clinical relevance of sHLA-G-mediated with better graft acceptance in early posttransplantation.
Jin HL; Li CR; Xiao L; Shi BY; Cai M; Li ZL; Wang S; Chen LP; Zhan SL; Li PC
Transplant Proc; 2012 Jun; 44(5):1259-61. PubMed ID: 22663996
[TBL] [Abstract][Full Text] [Related]
32. Immunotolerance in Liver Transplantation.
Mastoridis S; Martinez-Llordella M; Sanchez-Fueyo A
Semin Liver Dis; 2017 May; 37(2):95-108. PubMed ID: 28564719
[No Abstract] [Full Text] [Related]
33. Exploiting tolerance processes in transplantation.
Waldmann H; Cobbold S
Science; 2004 Jul; 305(5681):209-12. PubMed ID: 15247471
[TBL] [Abstract][Full Text] [Related]
34. Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients.
Nakamura Y; Hama K; Katayama H; Soga A; Toraishi T; Yokoyama T; Kihara Y; Jojima Y; Konno O; Iwamoto H; Takeuchi H; Hirano T; Shimazu M
Transplant Proc; 2012 Jan; 44(1):124-7. PubMed ID: 22310595
[TBL] [Abstract][Full Text] [Related]
35. Recent advances in immunosuppressive therapy for prevention of renal allograft rejection.
Lunsford KE; Barbas AS; Brennan TV
Curr Opin Organ Transplant; 2011 Aug; 16(4):390-7. PubMed ID: 21666473
[TBL] [Abstract][Full Text] [Related]
36. Soluble CD30 in renal transplant recipients: is it a good biomarker to predict rejection?
Azarpira N; Aghdaie MH; Malekpour Z
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):31-6. PubMed ID: 20061689
[TBL] [Abstract][Full Text] [Related]
37. Rationale and criteria of eligibility for calcineurin inhibitor interruption following kidney transplantation.
Danger R; Giral M; Soulillou JP; Brouard S
Curr Opin Organ Transplant; 2008 Dec; 13(6):609-13. PubMed ID: 19060551
[TBL] [Abstract][Full Text] [Related]
38. Longterm Survival and Cost-Effectiveness of Immunosuppression Withdrawal After Liver Transplantation.
Manzia TM; Angelico R; Toti L; Angelico C; Quaranta C; Parente A; Blasi F; Iesari S; Sforza D; Baiocchi L; Lerut J; Tisone G
Liver Transpl; 2018 Sep; 24(9):1199-1208. PubMed ID: 30129171
[TBL] [Abstract][Full Text] [Related]
39. Regulatory T cells as a therapeutic tool to induce solid-organ transplant tolerance: current clinical experiences.
Nikoueinejad H; Sharif MR; Amirzargar A; Mirshafiey A; Einollahi B
Exp Clin Transplant; 2013 Oct; 11(5):379-87. PubMed ID: 23902519
[TBL] [Abstract][Full Text] [Related]
40. Role of T cells in graft rejection and transplantation tolerance.
Issa F; Schiopu A; Wood KJ
Expert Rev Clin Immunol; 2010 Jan; 6(1):155-69. PubMed ID: 20383898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
